DR Habeerbullah Life Sciences Ltd.
Snapshot View

31.20 ▼0%

29 July 2021, 04:00:00 P.M.

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.pcproductslimited.com
Financial Indicators
Market Cap 46.20 Cr.
Earnings per share (EPS) -0.52 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 118.36 Trailing Twelve Months Ending 2021-03
Book Value / Share 7.44 Trailing Twelve Months Ending 2021-03
Price to Book Value 4.19 Calculated using Price: 31.20
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.48 Cr. 14,808,706 Shares
FaceValue 10
Company Profile

Dr. Habeebullah Life Sciences (formerly known as PC Products India) is a public company traded on the Bombay Stock Exchange (BSE), Metropolitan Stock Exchange of India and Ahmedabad Stock Exchange.

A diversified healthcare company with innovation at its heart, Dr. Habeebullah Life Sciences (DRHABEEB) (formerly known as PC Products India) is at the forefront of research and development in stem cells & regenerative medicine, new drug discovery, RNAi therapeutics, biomarker discovery. The Company was named after late Dr CM Habeebullah, whose dedication and passion form the backbone of the Company’s core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in the areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi-Specialty Hospital and CRO.

All services adhere to stringent quality systems and meet the requisite regulatory norms, with each department following its own quality control (QC) & quality assurance (QA) procedures.


Business area of the company

Dr Habeebullah Life Sciences with its group Companies has established platforms in the areas of Stem Cell Research and Therapy, New Drug Discovery, Molecular Prognosis and Diagnostics services, CRO, Stem Cell focused Super Specialty Hospital, RNA Interference Technology and Medical Devices.

Products

  • Stem Cell R&D
  • New Drug Discovery
  • RNA Interference
  • Molecular Biomarkers
  • Medical Devices

Services

  • Molecular diagnostics
  • Stem Cell Therapy
  • Clinical Services
  • Contract Research Organization
  • Academic Services

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
+0.81%
1 Month
+1.46%
3 Month
-19.69%
6 Month
-10.34%
1 Year
-26.85%
2 Year
-31.13%
5 Year
+321.62%
4 years 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -16.62 -11.85 -21.62 -16.88
Return on Capital Employed (%) -4.07 -6.81 -12.27 -10.10
Return on Assets (%) -6.90 -5.06 -9.63 -7.40

Balance Sheet View Details

Particulars 4 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 8 11 12 12
Non Curr. Liab. 0 0 0 0
Curr. Liab. 7 7 10 12
Minority Int. 4 4 4 4
Equity & Liab. 19 23 26 28
Non Curr. Assets 16 18 20 21
Curr. Assets 3 4 6 7
Misc. Exp. not W/O
Total Assets 19 23 26 28

Profit Loss View Details

Particulars 4 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 1 1 2 1
Other Income 0 0 0 0
Total Income 1 1 2 2
Total Expenditure -2 -2 -4 -4
PBIDT -1 -1 -2 -2
Interest 0 0
Depreciation 0 0 0 0
Taxation -1 0 0 0
Exceptional Items
PAT -1 -1 -2 -2

Cash Flow View Details

Particulars 4 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 -3 -3 -1
Cash Fr. Inv. -1 -1 -2 -1
Cash Fr. Finan. 1 5 4 2
Net Change 0 0 0 0
Cash & Cash Eqvt 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 58.27 62.46 58.27 58.27 58.27 58.27 58.27 58.27 58.27
Public 41.73 37.54 41.73 41.73 41.73 41.73 41.73 41.73 41.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 27 Jul 2021
Related Party Disclosure For The Quarter And Year Ended 31.03.2021
Related party disclosure for the quarter and year ended 31.03.2021
Wed, 21 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate u/r 74(5) of SEBI (DP) Regulations 2018
Wed, 21 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- KRISHNAM RAJU KALIDINDI
Designation :- Managing Director / Whole Time Director

Technical Scans View Details

Thu, 29 Jul 2021
Strongly Underperforming Benchmark index Strongly Underperforming Benchmark index
Increasing Relative Strength - Benchmark index Increasing Relative Strength - Benchmark index
Strongly Underperforming Sectoral index Strongly Underperforming Sectoral index
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
Close Within 2 Year Low Zone Close Within 2 Year Low Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 154,127.39 1,420.90 +1.4%
Adani Transmission Ltd. 103,690.09 903.75 -4.1%
Sundram Fasteners Ltd. 15,707.10 765.70 +2.4%
Redington (India) Ltd. 12,689.89 327.30 +0.7%
MMTC Ltd. 7,597.50 50.45 -0.4%
Novartis India Ltd. 2,318.59 960.15 +2.2%
MSTC Ltd. 2,031.04 284.05 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 167.05 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 84.71 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 43.73 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 16.78 327.30 +0.7%
MMTC Ltd. Standalone 2020-12 0.00 50.45 -0.4%
Novartis India Ltd. Standalone 2021-03 110.94 960.15 +2.2%
MSTC Ltd. Consolidated 2021-03 17.98 284.05 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 8.98 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 17.03 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 6.69 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 2.57 327.30 +0.7%
MMTC Ltd. Standalone 2020-12 7.52 50.45 -0.4%
Novartis India Ltd. Standalone 2021-03 3.26 960.15 +2.2%
MSTC Ltd. Consolidated 2021-03 3.64 284.05 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 4.89 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 0.29 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 0.09 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 4.23 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 0.00 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 0.55 284.05 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 22.81 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 16.70 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 17.02 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -20.23 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 1.36 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 23.14 284.05 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 7.88 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 10.89 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 17.31 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 21.81 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -2.16 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 4.73 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 22.93 284.05 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 9,926.33 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 3,644.29 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 26,304.71 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 438.25 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 1,231.40 284.05 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 1,289.57 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 362.71 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 786.61 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -220.48 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 10.08 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 99.71 284.05 -1.5%